3.606
price down icon0.66%   -0.024
 
loading
전일 마감가:
$3.63
열려 있는:
$3.59
하루 거래량:
8,331
Relative Volume:
2.03
시가총액:
$177.01M
수익:
-
순이익/손실:
-
주가수익비율:
-4.9121
EPS:
-0.7341
순현금흐름:
-
1주 성능:
-17.72%
1개월 성능:
-14.77%
6개월 성능:
+5.75%
1년 성능:
-32.97%
1일 변동 폭
Value
$3.54
$3.62
1주일 범위
Value
$3.54
$4.33
52주 변동 폭
Value
$2.55
$6.4229

Genfit Adr Stock (GNFT) Company Profile

Name
명칭
Genfit Adr
Name
전화
-
Name
주소
-
Name
직원
180
Name
트위터
@genfit_pharma
Name
다음 수익 날짜
2025-09-22
Name
최신 SEC 제출 서류
Name
GNFT's Discussions on Twitter

GNFT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GNFT
Genfit Adr
3.54 181.51M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
377.28 97.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.06 59.56B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.54 60.19B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
700.72 44.94B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.09 36.14B 3.81B -644.79M -669.77M -6.24

Genfit Adr Stock (GNFT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-08-19 재개 H.C. Wainwright Buy
2021-12-20 업그레이드 H.C. Wainwright Neutral → Buy
2020-07-23 업그레이드 Stifel Hold → Buy
2020-06-25 개시 BofA/Merrill Underperform
2020-05-13 다운그레이드 Kepler Buy → Reduce
2020-05-12 다운그레이드 Barclays Overweight → Equal Weight
2020-05-12 다운그레이드 H.C. Wainwright Buy → Neutral
2019-10-29 재확인 B. Riley FBR Buy
2019-06-25 개시 Stifel Hold
2019-04-24 개시 SVB Leerink Outperform
2019-04-22 개시 Barclays Overweight
모두보기

Genfit Adr 주식(GNFT)의 최신 뉴스

pulisher
08:20 AM

FY2025 EPS Estimates for GENFIT Lifted by Leerink Partnrs - MarketBeat

08:20 AM
pulisher
02:51 AM

GENFIT (NASDAQ:GNFT) Price Target Lowered to $7.00 at HC Wainwright - Defense World

02:51 AM
pulisher
Sep 24, 2025

HC Wainwright Has Lowered Expectations for GENFIT (NASDAQ:GNFT) Stock Price - MarketBeat

Sep 24, 2025
pulisher
Sep 11, 2025

European ADRs Dip Slightly As Biotech Stocks Jump And Drop - Finimize

Sep 11, 2025
pulisher
Aug 20, 2025

GENFIT (NASDAQ:GNFT) Coverage Initiated by Analysts at HC Wainwright - Defense World

Aug 20, 2025
pulisher
Aug 15, 2025

European Biopharma ADRs: A Strategic Play in a Volatile Market - AInvest

Aug 15, 2025
pulisher
Jul 10, 2025

GENFIT (NASDAQ:GNFT) Shares Up 0.7% – Time to Buy? - Defense World

Jul 10, 2025
pulisher
Jun 30, 2025

European ADRs: Navigating Sectoral Divergence in a Volatile Market - AInvest

Jun 30, 2025
pulisher
Jun 27, 2025

European Biopharma Leads Gains In ADR Market Surge - Finimize

Jun 27, 2025
pulisher
Jun 27, 2025

European Biotech ADRs Lead the Charge: A Sector on the Verge of Breakthrough Growth - AInvest

Jun 27, 2025
pulisher
May 31, 2025

European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize

May 31, 2025
pulisher
May 22, 2025

European ADRs Show Optimism As Genfit Leads Gains - Finimize

May 22, 2025
pulisher
May 07, 2025

European ADRs See Mixed Results With Modest Gains - Finimize

May 07, 2025
pulisher
Apr 11, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - TradingView

Apr 11, 2025
pulisher
Apr 09, 2025

European ADRs Climb As Biopharmaceuticals Lead The Charge - Finimize

Apr 09, 2025
pulisher
Apr 08, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView

Apr 08, 2025
pulisher
Apr 03, 2025

European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - TradingView

Apr 03, 2025
pulisher
Apr 01, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading - TradingView

Apr 01, 2025
pulisher
Mar 28, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView

Mar 28, 2025
pulisher
Mar 27, 2025

European Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading - TradingView

Mar 27, 2025
pulisher
Mar 26, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - TradingView

Mar 26, 2025
pulisher
Mar 24, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - TradingView

Mar 24, 2025
pulisher
Mar 18, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView

Mar 18, 2025
pulisher
Mar 14, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down for Week - TradingView

Mar 14, 2025
pulisher
Mar 03, 2025

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading - TradingView

Mar 03, 2025
pulisher
Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025
pulisher
Jun 10, 2024

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis - GlobeNewswire

Jun 10, 2024
pulisher
Dec 07, 2023

Ipsen confirms U.S. FDA grants priority review for New Drug - GlobeNewswire

Dec 07, 2023
pulisher
Nov 13, 2023

Results from Ipsen’s ELATIVE® pivotal Phase III trial of - GlobeNewswire

Nov 13, 2023
pulisher
Dec 17, 2021

Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership - Business Wire

Dec 17, 2021

Genfit Adr (GNFT) 재무 분석

Genfit Adr (GNFT)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$34.99
price down icon 2.15%
$81.92
price down icon 2.65%
$28.80
price down icon 2.22%
$98.02
price down icon 1.75%
$136.38
price down icon 3.33%
biotechnology ONC
$326.56
price down icon 0.76%
자본화:     |  볼륨(24시간):